ArticleOncogene2025

Correction: Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer.

Joy C Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.